Cargando…
Cell-Free Expression of Sodium Channel Domains for Pharmacology Studies. Noncanonical Spider Toxin Binding Site in the Second Voltage-Sensing Domain of Human Na(v)1.4 Channel
Voltage-gated sodium (Na(V)) channels are essential for the normal functioning of cardiovascular, muscular, and nervous systems. These channels have modular organization; the central pore domain allows current flow and provides ion selectivity, whereas four peripherally located voltage-sensing domai...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737007/ https://www.ncbi.nlm.nih.gov/pubmed/31555136 http://dx.doi.org/10.3389/fphar.2019.00953 |
_version_ | 1783450594190557184 |
---|---|
author | Myshkin, Mikhail Yu. Männikkö, Roope Krumkacheva, Olesya A. Kulbatskii, Dmitrii S. Chugunov, Anton O. Berkut, Antonina A. Paramonov, Alexander S. Shulepko, Mikhail A. Fedin, Matvey V. Hanna, Michael G. Kullmann, Dimitri M. Bagryanskaya, Elena G. Arseniev, Alexander S. Kirpichnikov, Mikhail P. Lyukmanova, Ekaterina N. Vassilevski, Alexander A. Shenkarev, Zakhar O. |
author_facet | Myshkin, Mikhail Yu. Männikkö, Roope Krumkacheva, Olesya A. Kulbatskii, Dmitrii S. Chugunov, Anton O. Berkut, Antonina A. Paramonov, Alexander S. Shulepko, Mikhail A. Fedin, Matvey V. Hanna, Michael G. Kullmann, Dimitri M. Bagryanskaya, Elena G. Arseniev, Alexander S. Kirpichnikov, Mikhail P. Lyukmanova, Ekaterina N. Vassilevski, Alexander A. Shenkarev, Zakhar O. |
author_sort | Myshkin, Mikhail Yu. |
collection | PubMed |
description | Voltage-gated sodium (Na(V)) channels are essential for the normal functioning of cardiovascular, muscular, and nervous systems. These channels have modular organization; the central pore domain allows current flow and provides ion selectivity, whereas four peripherally located voltage-sensing domains (VSDs-I/IV) are needed for voltage-dependent gating. Mutations in the S4 voltage-sensing segments of VSDs in the skeletal muscle channel Na(V)1.4 trigger leak (gating pore) currents and cause hypokalemic and normokalemic periodic paralyses. Previously, we have shown that the gating modifier toxin Hm-3 from the crab spider Heriaeus melloteei binds to the S3-S4 extracellular loop in VSD-I of Na(V)1.4 channel and inhibits gating pore currents through the channel with mutations in VSD-I. Here, we report that Hm-3 also inhibits gating pore currents through the same channel with the R675G mutation in VSD-II. To investigate the molecular basis of Hm-3 interaction with VSD-II, we produced the corresponding 554-696 fragment of Na(V)1.4 in a continuous exchange cell-free expression system based on the Escherichia coli S30 extract. We then performed a combined nuclear magnetic resonance (NMR) and electron paramagnetic resonance spectroscopy study of isolated VSD-II in zwitterionic dodecylphosphocholine/lauryldimethylamine-N-oxide or dodecylphosphocholine micelles. To speed up the assignment of backbone resonances, five selectively (13)C,(15)N-labeled VSD-II samples were produced in accordance with specially calculated combinatorial scheme. This labeling approach provides assignment for ∼50% of the backbone. Obtained NMR and electron paramagnetic resonance data revealed correct secondary structure, quasi-native VSD-II fold, and enhanced ps–ns timescale dynamics in the micelle-solubilized domain. We modeled the structure of the VSD-II/Hm-3 complex by protein–protein docking involving binding surfaces mapped by NMR. Hm-3 binds to VSDs I and II using different modes. In VSD-II, the protruding ß-hairpin of Hm-3 interacts with the S1-S2 extracellular loop, and the complex is stabilized by ionic interactions between the positively charged toxin residue K24 and the negatively charged channel residues E604 or D607. We suggest that Hm-3 binding to these charged groups inhibits voltage sensor transition to the activated state and blocks the depolarization-activated gating pore currents. Our results indicate that spider toxins represent a useful hit for periodic paralyses therapy development and may have multiple structurally different binding sites within one Na(V) molecule. |
format | Online Article Text |
id | pubmed-6737007 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67370072019-09-25 Cell-Free Expression of Sodium Channel Domains for Pharmacology Studies. Noncanonical Spider Toxin Binding Site in the Second Voltage-Sensing Domain of Human Na(v)1.4 Channel Myshkin, Mikhail Yu. Männikkö, Roope Krumkacheva, Olesya A. Kulbatskii, Dmitrii S. Chugunov, Anton O. Berkut, Antonina A. Paramonov, Alexander S. Shulepko, Mikhail A. Fedin, Matvey V. Hanna, Michael G. Kullmann, Dimitri M. Bagryanskaya, Elena G. Arseniev, Alexander S. Kirpichnikov, Mikhail P. Lyukmanova, Ekaterina N. Vassilevski, Alexander A. Shenkarev, Zakhar O. Front Pharmacol Pharmacology Voltage-gated sodium (Na(V)) channels are essential for the normal functioning of cardiovascular, muscular, and nervous systems. These channels have modular organization; the central pore domain allows current flow and provides ion selectivity, whereas four peripherally located voltage-sensing domains (VSDs-I/IV) are needed for voltage-dependent gating. Mutations in the S4 voltage-sensing segments of VSDs in the skeletal muscle channel Na(V)1.4 trigger leak (gating pore) currents and cause hypokalemic and normokalemic periodic paralyses. Previously, we have shown that the gating modifier toxin Hm-3 from the crab spider Heriaeus melloteei binds to the S3-S4 extracellular loop in VSD-I of Na(V)1.4 channel and inhibits gating pore currents through the channel with mutations in VSD-I. Here, we report that Hm-3 also inhibits gating pore currents through the same channel with the R675G mutation in VSD-II. To investigate the molecular basis of Hm-3 interaction with VSD-II, we produced the corresponding 554-696 fragment of Na(V)1.4 in a continuous exchange cell-free expression system based on the Escherichia coli S30 extract. We then performed a combined nuclear magnetic resonance (NMR) and electron paramagnetic resonance spectroscopy study of isolated VSD-II in zwitterionic dodecylphosphocholine/lauryldimethylamine-N-oxide or dodecylphosphocholine micelles. To speed up the assignment of backbone resonances, five selectively (13)C,(15)N-labeled VSD-II samples were produced in accordance with specially calculated combinatorial scheme. This labeling approach provides assignment for ∼50% of the backbone. Obtained NMR and electron paramagnetic resonance data revealed correct secondary structure, quasi-native VSD-II fold, and enhanced ps–ns timescale dynamics in the micelle-solubilized domain. We modeled the structure of the VSD-II/Hm-3 complex by protein–protein docking involving binding surfaces mapped by NMR. Hm-3 binds to VSDs I and II using different modes. In VSD-II, the protruding ß-hairpin of Hm-3 interacts with the S1-S2 extracellular loop, and the complex is stabilized by ionic interactions between the positively charged toxin residue K24 and the negatively charged channel residues E604 or D607. We suggest that Hm-3 binding to these charged groups inhibits voltage sensor transition to the activated state and blocks the depolarization-activated gating pore currents. Our results indicate that spider toxins represent a useful hit for periodic paralyses therapy development and may have multiple structurally different binding sites within one Na(V) molecule. Frontiers Media S.A. 2019-09-04 /pmc/articles/PMC6737007/ /pubmed/31555136 http://dx.doi.org/10.3389/fphar.2019.00953 Text en Copyright © 2019 Myshkin, Männikkö, Krumkacheva, Kulbatskii, Chugunov, Berkut, Paramonov, Shulepko, Fedin, Hanna, Kullmann, Bagryanskaya, Arseniev, Kirpichnikov, Lyukmanova, Vassilevski and Shenkarev http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Myshkin, Mikhail Yu. Männikkö, Roope Krumkacheva, Olesya A. Kulbatskii, Dmitrii S. Chugunov, Anton O. Berkut, Antonina A. Paramonov, Alexander S. Shulepko, Mikhail A. Fedin, Matvey V. Hanna, Michael G. Kullmann, Dimitri M. Bagryanskaya, Elena G. Arseniev, Alexander S. Kirpichnikov, Mikhail P. Lyukmanova, Ekaterina N. Vassilevski, Alexander A. Shenkarev, Zakhar O. Cell-Free Expression of Sodium Channel Domains for Pharmacology Studies. Noncanonical Spider Toxin Binding Site in the Second Voltage-Sensing Domain of Human Na(v)1.4 Channel |
title | Cell-Free Expression of Sodium Channel Domains for Pharmacology Studies. Noncanonical Spider Toxin Binding Site in the Second Voltage-Sensing Domain of Human Na(v)1.4 Channel |
title_full | Cell-Free Expression of Sodium Channel Domains for Pharmacology Studies. Noncanonical Spider Toxin Binding Site in the Second Voltage-Sensing Domain of Human Na(v)1.4 Channel |
title_fullStr | Cell-Free Expression of Sodium Channel Domains for Pharmacology Studies. Noncanonical Spider Toxin Binding Site in the Second Voltage-Sensing Domain of Human Na(v)1.4 Channel |
title_full_unstemmed | Cell-Free Expression of Sodium Channel Domains for Pharmacology Studies. Noncanonical Spider Toxin Binding Site in the Second Voltage-Sensing Domain of Human Na(v)1.4 Channel |
title_short | Cell-Free Expression of Sodium Channel Domains for Pharmacology Studies. Noncanonical Spider Toxin Binding Site in the Second Voltage-Sensing Domain of Human Na(v)1.4 Channel |
title_sort | cell-free expression of sodium channel domains for pharmacology studies. noncanonical spider toxin binding site in the second voltage-sensing domain of human na(v)1.4 channel |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737007/ https://www.ncbi.nlm.nih.gov/pubmed/31555136 http://dx.doi.org/10.3389/fphar.2019.00953 |
work_keys_str_mv | AT myshkinmikhailyu cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT mannikkoroope cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT krumkachevaolesyaa cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT kulbatskiidmitriis cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT chugunovantono cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT berkutantoninaa cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT paramonovalexanders cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT shulepkomikhaila cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT fedinmatveyv cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT hannamichaelg cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT kullmanndimitrim cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT bagryanskayaelenag cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT arsenievalexanders cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT kirpichnikovmikhailp cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT lyukmanovaekaterinan cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT vassilevskialexandera cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel AT shenkarevzakharo cellfreeexpressionofsodiumchanneldomainsforpharmacologystudiesnoncanonicalspidertoxinbindingsiteinthesecondvoltagesensingdomainofhumannav14channel |